Drug and Nondrug Therapies for Atopic Dermatitis
Health ConditionsSkin ConditionsEczema

Atopic Dermatitis Treatments: Drug and Nondrug Therapies

Atopic Dermatitis Treatments: Drug and Nondrug Therapies
Getty Images
By
Updated on February 3, 2026
by

There is no cure for atopic dermatitis, but there are treatments that can ease symptoms like itch and inflammation and reduce flare-ups.

Medications, moisturizers, and at-home skin-care routines are all part of an effective treatment plan.

Illustrative graphic titled Atopic Dermatitis Treatment Options shows Topical Steroids Systemic Corticosteroids Topical Non-Steroid Medications Immunosuppressants Oral JAK Inhibitors Biologics Light Therapy Wet-Wrap Therapy Complementary Home Remedies.
Everyday Health

Topical Steroids for Treating Atopic Dermatitis

Topical corticosteroids (steroids) are the standard, go-to treatment for atopic dermatitis flare-ups.

Applied directly to the affected areas of skin, these ointments, creams, or lotions can reduce inflammation and itch.

Topical corticosteroids come in varying degrees of strength — with 1 being the most powerful and 7 being the weakest. For example, the ultra-high-potency steroid clobetasol is a class 1 medication, while over-the-counter hydrocortisone creams are in the least potent class 7.

Topical corticosteroids should not be used as moisturizers and should only be applied to areas of the skin that are affected by atopic dermatitis, as often as your doctor recommends.

With excessive use, these drugs can thin the skin, cause spider veins, or result in stretch marks, among other side effects.

Rarely, topical corticosteroids can be absorbed into the skin and enter the bloodstream, causing side effects that can affect the whole body. These more severe side effects may include:

  • Eye problems (glaucoma and cataracts)
  • Slowed growth in children
  • Hypothalamic-pituitary-adrenal axis suppression
  • Topical steroid withdrawal
  • Tachyphylaxis, where the skin becomes tolerant to the steroid and it doesn’t work anymore

Systemic Corticosteroids

If topical corticosteroids aren’t working, or in more severe cases of atopic dermatitis, doctors may in rare cases prescribe a systemic (whole body) corticosteroid, taken by mouth or injected.

Doctors only recommend taking systemic corticosteroids for short periods of time, because these drugs can result in a “rebound effect,” in which symptoms return and can be even worse once you stop taking these medications. Using oral steroids for more than a month can also cause serious side effects including:

  • An increase in bacterial, fungal, and viral infections
  • Skin thinning, stretch marks, and acne
  • Hair loss
  • Weight gain
  • Glaucoma
  • Cataracts
  • High blood pressure
  • Gastrointestinal (stomach) issues
  • Stunted growth in children
  • Irregular menstruation
  • Osteoporosis

Other Topical Medications for Atopic Dermatitis

Topical calcineurin inhibitors (TCIs) are another category of prescription medication for atopic dermatitis that includes tacrolimus (Protopic) and pimecrolimus (Elidel).

TCIs control inflammation and reduce atopic dermatitis flare-ups by suppressing the immune system. They don’t contain steroids, and they're typically prescribed when topical steroids are ineffective or aren’t well tolerated. They can also be prescribed for delicate areas of the skin, such as the eyelids or groin folds, where it’s important to prevent thinning of the skin.

In 2006, based on animal studies and oral ingestion of TCIs, the U.S. Food and Drug Administration (FDA) added a box warning for TCIs because of a potential increased risk of lymphoma. However, a systematic review and meta-analysis published in 2023 found moderate-certainty evidence showing that TCIs don’t increase the risk of cancer among people with atopic dermatitis.

PDE4 inhibitors work by blocking an enzyme called phosphodiesterase 4 (PDE4) from producing too much inflammation in the body. Until recently, there was only one PDE4 inhibitor on the market that was approved by the FDA for atopic dermatitis: crisaborole (Eucrisa).

 However, in July 2024, another PDE4 inhibitor, roflumilast (Zoryve), was approved for eczema in patients 6 years old and older.

Topical JAK inhibitors, specifically the skin creams delgocitinib (Anzupgo) and ruxolitinib (Opzelura) work by blocking enzymes involved in the path of several immune system messengers in the blood and skin that can lead to inflammation.

The FDA added a box warning to this medication because of the risk of serious infections and other potentially severe complications.

Aryl hydrocarbon receptor agonists are a new steroid-free option for atopic dermatitis. In December 2024, the FDA approved an aryl hydrocarbon receptor agonist called tapinarof cream 1 percent (Vtama) to treat atopic dermatitis in adults and children ages 2 or older.

 Vtama works by decreasing inflammation and normalizing proteins on the skin barrier to help the skin barrier function properly.

Oral and Injectable Medications

Several oral and injectable medications have also been approved to help manage atopic dermatitis symptoms such as itching.

Biologics

Biologics target specific parts of the immune system that contribute to inflammatory diseases such as atopic dermatitis.

 Two biologic drugs have been approved by the FDA to treat atopic dermatitis. Both are injected subcutaneously (through the skin), and can be self-administered.

Dupilumab (Dupixent) is approved to treat adults and children 6 months old and older with moderate to severe atopic dermatitis that hasn't responded well to topical medications. Dupilumab works by blocking the activity of certain inflammatory chemicals in the body.

The common side effects of dupilumab are generally mild, and they include:

  • Eyelid and eye inflammation
  • Injection site reactions
  • Cold sores
Tralokinumab-ldrm (Adbry) is approved to treat people 12 years old and older with moderate to severe atopic dermatitis that hasn't responded well to topical medications. It works by blocking a protein that plays a role in the body’s immune response that leads to inflammation of the skin.

The most common side effects of Adbry include:

  • Upper respiratory tract infections
  • Eye and eyelid inflammation
  • Reaction at the injection site
  • High eosinophil count (a type of white blood cell)
Lebrikizumab-lbkz (Ebglyss) was approved by the FDA in September 2024 for the treatment of atopic dermatitis in adults and children ages 12 and older.

 Ebglyss works by minimizing eczema-related inflammation in the body that can result in dry, itchy and irritated skin. The most common side effects of Ebglyss are eye and eyelid inflammation (including redness, swelling, and itching), reactions at the injection site, and shingles (herpes zoster).

Nemolizumab (Nemluvio) was approved in December 2024 by the FDA to treat moderate to severe atopic dermatitis in combination with topical corticosteroids or calcineurin inhibitors in patients ages 12 or older. This treatment is intended for people whose atopic dermatitis has not adequately improved with topical prescription treatments.

Nemluvio works by targeting a protein in the body that leads to itch and inflammation in atopic dermatitis. The most common side effects of Nemluvio in people with eczema include:

  • Headache
  • Hives
  • Joint pain
  • Muscle aches

Systemic Immunosuppressants

In moderate to severe cases of atopic dermatitis, doctors may prescribe a systemic immunosuppressant, such as cyclosporine (Neoral or Sandimmune), azathioprine, methotrexate (Trexall or Rasuvo), or mycophenolate mofetil (CellCept).

 These drugs help control or suppress the immune system to stop the itch-scratch cycle and allow the skin to heal.

When prescribed for atopic dermatitis, immunosuppressants are considered “off-label” because they are not approved by the FDA for this use.

These drugs can have potentially serious side effects, such as an increased risk of developing dangerous infections and cancers, and are not recommended for long-term use.

Oral JAK Inhibitors

JAK inhibitors are a relatively new class of oral immunomodulators that can block immune system signals and thereby reduce inflammation and itch.

The FDA has approved two oral JAK inhibitors, upadacitinib (Rinvoq) and abrocitinib (Cibinqo), to treat moderate to severe atopic dermatitis.

Rinvoq and Cibinqo are not recommended for use in combination with other JAK inhibitors, biologics, or other immunosuppressants. The FDA has placed a box warning on these medications for potentially increasing the risk of all-cause mortality, serious infections, certain cancers (including lymphoma), heart attack, stroke, and thrombosis (blood clots).

What Are Common Triggers and Treatments for Atopic Dermatitis?

Dermatologist Andrew Alexis, MD, walks through some factors that can worsen atopic dermatitis, as well as potential treatment options.
What Are Common Triggers and Treatments for Atopic Dermatitis?

Next up video playing in 10 seconds

Medications at a Glance

Here’s a quick roundup of the different types of medications discussed earlier in the article to help you compare them more easily:

Drug Class
How It works
Common Side Effects
Topical steroids (e.g., hydrocortisone, betamethasone clobetasol, fluticasone)
  • Applied to areas of skin affected by atopic dermatitis
  • Reduces irritation and itch
  • Skin thinning
  • Spider veins
  • Stretch marks
  • Hypopigmentation
Systemic corticosteroids (e.g., prednisone)
  • Taken by mouth or injected only in severe situations and for short periods
  • Reduces inflammation, redness, irritation, and weeping
  • Increased risk of infection due to immune system suppression
  • Weight gain
  • Stomach issues
  • Cataracts and glaucoma
  • Easy bruising, skin thinning, and stretch marks
  • Altered mood
  • Effects on growth and bone formation (in children)
  • Osteoporosis (in older adults)
Topical medications without steroids
  • Topical calcineurin inhibitors (TCIS), such as tacrolimus or pimecrolimus, suppress the immune system to reduce flare-ups.
  • PDE4 inhibitors (e.g., crisaborole, roflumilast) block an enzyme from producing inflammation in the body.
  • Topical JAK inhibitors (e.g., ruxolitinib) interact with immune system messengers in the blood that can lead to inflammation.
  • Aryl hydrocarbon receptor agonists (e.g., Vtama) decrease inflammation and help the skin barrier function properly.
  • TCIs have a boxed warning for a potential increased risk of lymphoma; they may also cause a burning or stinging during application and may make skin more sensitive to sunlight.
  • PDE4 inhibitors may cause stomach issues like nausea and vomiting, skin reactions at application and hypersensitivity of skin, headaches, and mood changes.
  • Topical JAK inhibitors present a risk of serious infections and other severe complications.
  • In clinical studies of Vtama, side effects included upper or lower respiratory tract infections, folliculitis, headache, asthma, vomiting, ear infections, and pain.
Biologics (e.g., dupilumab, tralokinumab-idrm, nemolizumab)
  • Injected under the skin or administered intravenously
  • Specifically targets parts of the immune system that contribute to inflammatory diseases and manage symptoms, such as itching
  • Injection site reactions
  • Eye and eyelid inflammation
  • Infections, aches, or pains
Immunosuppressants (e.g., cyclosporine, azathioprine, methotrexate)
  • May be applied topically, taken orally, or injected, depending on the medication and only for short-term use
  • Manages and suppresses the immune system to stop the itch-scratch cycle and help skin heal
  • Increased risk of infections and cancer
Oral JAK inhibitors (e.g., upadacitinib, abrocitinib)
  • Taken by mouth
  • Blocks immune system signals to reduce inflammation and itch

FDA boxed warning notes that it potentially increases the risk of:

  • All-cause mortality
  • Serious infections
  • Certain cancers (including lymphoma)
  • Heart attack
  • Stroke
  • Thrombosis (blood clots)

Additional Treatments for Atopic Dermatitis

Antihistamines

Doctors may recommend certain antihistamines for atopic dermatitis to make it easier to sleep through the night, and to reduce inflammation and itch if you have allergies.

Light Therapy

Light therapy (phototherapy) using ultraviolet waves can help improve itch and inflammation. The treatment is typically prescribed for people whose atopic dermatitis hasn’t improved with topical treatments.

Skin improvements usually don’t occur immediately, but instead become evident after one to two months of treatments.

Sunburns, skin tenderness, and premature skin aging are common side effects. Less common potential side effects include cataracts and skin eruptions.

Wet-Wrap Therapy

Wet wrap therapy can help rehydrate and calm the skin during intense eczema flares. It can also help topical medications work better. In wet-wrap therapy, fabric wraps are soaked in water and applied to the affected skin, typically after bathing, moisturizing, and applying medication. Talk to your doctor before you try wet wrap therapy.

Home Treatments for Atopic Dermatitis

In addition to seeking help from a doctor, people with atopic dermatitis may be able to take a few steps on their own to reduce itching and the need for medication.

These measures include:

  • Keeping fingernails short and wearing gloves at night to avoid scratching the skin

  • Moisturizing skin frequently with ointments (petroleum jelly), creams, and lotions that are free of alcohol, fragrances, and dyes
  • Using a humidifier, particularly if the air is dry
  • Avoiding skin irritants, such as wool or man-made fibers (wear soft cotton clothing instead), strong soaps and detergents, and situations or environments that cause sweating

  • Avoiding airborne allergens, such as pollen, pet dander, and dust mites
When bathing, it's important to minimize time in the tub or shower (aim for no more than 10 to 15 minutes) and to use cool or lukewarm water. Use gentle body washes and cleansers, and avoid scrubbing or toweling off for too long.

Also be sure to apply a moisturizer immediately after drying off.

Complementary and Integrative Therapies for Atopic Dermatitis

While you can’t cure atopic dermatitis naturally, some people have found relief with the following home treatments:

  • Adding a quarter cup of baking soda, a cup of table salt, a cup of vinegar, fragrance-free bath oils, or a half cup of bleach to a full tub of bathwater

  • Managing stress through massage, yoga, qigong, tai chi, mindfulness meditation, hypnosis, or biofeedback

  • Acupuncture and acupressure
  • Using oils like coconut oil and sunflower seed oil (ask your doctor before using any new product on your skin, including oils)

Questions to Ask Your Doctor

  • How do you get rid of eczema fast?
  • What is the most effective treatment for eczema?
  • What creams can I use for atopic dermatitis?
  • What are some medications I can take for eczema?
  • What is the first line of treatment for atopic dermatitis?
  • What is the most effective treatment for atopic dermatitis?
  • Does light therapy get rid of eczema?
  • What are the side effects of steroids for eczema?

Diet and Supplements for Atopic Dermatitis

Food allergies are common among people with atopic dermatitis — about 30 percent of people with the skin condition also have food allergies. Allergies and food sensitivities can also trigger atopic dermatitis flares, but this is much more common in children than adults. Common food allergies and food sensitivities among people with atopic dermatitis include seafood, peanuts, dairy, eggs, sugar, alcohol, and gluten.

While elimination diets are generally not recommended for atopic dermatitis, the National Eczema Association recommends getting tested for food allergies before removing any foods from your diet.

In addition to avoiding known food allergies, experts say an anti-inflammatory diet can help some people with atopic dermatitis. This diet involves avoiding trans fats (hydrogenated oils, margarine, fried foods), saturated fats (red meats, full-fat dairy foods, butter, and poultry skin), refined carbs (white rice, white bread, and white pasta), and added sugars, and eating more omega-3 fatty acids (fatty fish, flaxseed, walnuts), green leafy vegetables, fruits, and whole grains.

Supplements for Atopic Dermatitis

Some people who have atopic dermatitis report that certain vitamins and dietary supplements offer some relief from symptoms. These commonly include:

  • Fish oil
  • Vitamin D
  • Vitamin C
  • Zinc
  • Selenium
  • Melatonin
  • Turmeric
  • Primrose Oil
  • CBD
  • Prebiotics and probiotics

There isn’t a lot of research or evidence to prove that any vitamins or supplements are safe and effective for treating atopic dermatitis, and some may be harmful when taken with prescription medication. Always talk to your doctor before taking a new vitamin or supplement.

The Takeaway

  • Treating atopic dermatitis can involve a variety of approaches.

  • Treatments may include topical, oral, or injectable medications; light therapy; and antihistamines, among other options.
  • Self-care and lifestyle changes are a key part of the equation, too. Strategies like bleach baths, dietary changes, and relaxation techniques to manage stress can help.

Resources We Trust

EDITORIAL SOURCES
Everyday Health follows strict sourcing guidelines to ensure the accuracy of its content, outlined in our editorial policy. We use only trustworthy sources, including peer-reviewed studies, board-certified medical experts, patients with lived experience, and information from top institutions.
Resources
  1. Eczema Topical Treatments. National Eczema Association.
  2. Eczema: Learn More – Steroids and Other Topical Medications. InformedHealth.org. February 11, 2021.
  3. Available Eczema Treatments. National Eczema Association.
  4. Devasenapathy N et al. Cancer Risk With Topical Calcineurin Inhibitors, Pimecrolimus and Tacrolimus, for Atopic Dermatitis: A Systematic Review and Meta-Analysis. The Lancet Child & Adolescent Health. January 2023.
  5. Eczema Treatment: Crisaborole (Eucrisa®) Ointment. American Academy of Dermatology Association. January 31, 2023.
  6. FDA Approves Arcutis’ ZORYVE® (roflumilast) Cream 0.15% for the Treatment of Atopic Dermatitis in Adults and Children Down to 6 Years of Age. GlobeNewswire. July 9, 2024.
  7. FAQ - Opzelura (Ruxolitinib) Cream. National Eczema Association.
  8. FDA Approves VTAMA® (tapinarof) cream, 1% for the Treatment of Atopic Dermatitis in Adults and Children 2 Years of Age and Older. Organon. December 16, 2024.
  9. Vtama (tapinarof) cream 1%. Dermavant.
  10. Dupixent Dosing for Eczema. Dupixent.
  11. FAQ – Adbry (Tralokinumab-ldrm). National Eczema Association.
  12. Getting Started & Staying On Adbry. Adbry.
  13. FDA Approves Lilly's EBGLYSSTM (lebrikizumab-lbkz) for Adults and Children 12 Years and Older with Moderate-to-Severe Atopic Dermatitis. Lilly. September 13, 2024.
  14. Galderma Receives U.S. FDA Approval for Nemluvio® (Nemolizumab) for Patients with Moderate-to-Severe Atopic Dermatitis. Galderma. September 14, 2024.
  15. Johnson JL. A Look at Current Guidelines for Topical Steroid Use for Atopic Dermatitis. National Eczema Association. September 17, 2024.
  16. Oral Steroids. National Eczema Society.
  17. Topical Calcineurin Inhibitors (TCIs). National Eczema Society.
  18. Phosphodiesterase Inhibitors. Cleveland Clinic. June 8, 2022.
  19. FAQ - Vtama (Tapinarof) Cream. National Eczema Association.
  20. Prescription Phototherapy. National Eczema Association.
  21. Wet Wrap Therapy. National Eczema Association.
  22. Eczema: Back to the Basics. National Eczema Association. July 15, 2021.
  23. Eczema Causes and Triggers. National Eczema Association. July 15, 2021.
  24. Eczema and Bathing. National Eczema Association.
  25. Alternative Treatments for Eczema. National Eczema Association.
  26. Everything You Need to Know About Eczema and Food Allergies. National Eczema Association. July 15, 2021.
  27. Jodi L. Johnson, PhD. A Look at the Food Elimination Diet Trend for Atopic Dermatitis. National Eczema Association. January 3, 2024.
Meet Our Experts
See Our Editorial PolicyMeet Our Health Expert Network
Susan-Bard-bio

Susan Bard, MD

Medical Reviewer
Castle Connolly Top Doctor

Susan Bard, MD, is a clinical instructor in the department of dermatology at Weill Cornell Medicine and an adjunct clinical instructor in the department of dermatology at Mount Sinai in New York City. Her professional interests include Mohs micrographic surgery, cosmetic and laser procedures, and immunodermatology.

She is a procedural dermatologist with the American Board of Dermatology and a fellow of the American College of Mohs Surgery.

Dr. Bard has written numerous book chapters and articles for many prominent peer-reviewed journals, and authored the textbook The Laser Treatment of Vascular Lesions.

See full bio

Joseph Bennington-Castro

Author

Joseph Bennington-Castro is a science writer based in Hawaii. He has written well over a thousand articles for the general public on a wide range topics, including health, astronomy, archaeology, renewable energy, biomaterials, conservation, history, animal behavior, artificial intelligence, and many others.

In addition to writing for Everyday Health, Bennington-Castro has also written for publications such as Scientific American, National Geographic online, USA Today, Materials Research Society, Wired UK, Men's Journal, Live Science, Space.com, NBC News Mach, NOAA Fisheries, io9.com, and Discover.

See full bio
See Our Editorial PolicyMeet Our Health Expert Network